[go: up one dir, main page]

NO995225L - Fremgangsmåte ved fremstilling av mometason furoat - Google Patents

Fremgangsmåte ved fremstilling av mometason furoat

Info

Publication number
NO995225L
NO995225L NO995225A NO995225A NO995225L NO 995225 L NO995225 L NO 995225L NO 995225 A NO995225 A NO 995225A NO 995225 A NO995225 A NO 995225A NO 995225 L NO995225 L NO 995225L
Authority
NO
Norway
Prior art keywords
preparing
mometasone furoate
mometasone
furoate
free
Prior art date
Application number
NO995225A
Other languages
English (en)
Other versions
NO321154B1 (no
NO995225D0 (no
Inventor
William Heggie
Joao Bandarra
Original Assignee
Hovione Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Int Ltd filed Critical Hovione Int Ltd
Publication of NO995225D0 publication Critical patent/NO995225D0/no
Publication of NO995225L publication Critical patent/NO995225L/no
Publication of NO321154B1 publication Critical patent/NO321154B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19995225A 1999-08-02 1999-10-26 Fremgangsmate ved fremstilling av mometason furoat NO321154B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT102343A PT102343B (pt) 1999-08-02 1999-08-02 Processo para a preparacao de furoato mometasona

Publications (3)

Publication Number Publication Date
NO995225D0 NO995225D0 (no) 1999-10-26
NO995225L true NO995225L (no) 2001-02-05
NO321154B1 NO321154B1 (no) 2006-03-27

Family

ID=20085881

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995225A NO321154B1 (no) 1999-08-02 1999-10-26 Fremgangsmate ved fremstilling av mometason furoat

Country Status (22)

Country Link
US (1) US6177560B1 (no)
EP (1) EP1074558B1 (no)
JP (1) JP3746174B2 (no)
KR (1) KR100640066B1 (no)
CN (1) CN1149222C (no)
AT (1) ATE229970T1 (no)
AU (1) AU765592B2 (no)
CA (1) CA2295455C (no)
DE (1) DE69904585T2 (no)
DK (1) DK1074558T3 (no)
ES (1) ES2189354T3 (no)
HR (1) HRP990341B1 (no)
HU (1) HU227494B1 (no)
IL (1) IL133752A (no)
NO (1) NO321154B1 (no)
NZ (1) NZ500555A (no)
PL (1) PL191103B1 (no)
PT (1) PT102343B (no)
RU (1) RU2208616C2 (no)
SI (1) SI1074558T1 (no)
UA (1) UA60333C2 (no)
ZA (1) ZA996758B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
EP1790754A1 (de) * 2005-11-24 2007-05-30 Siemens Aktiengesellschaft Schichtsystem mit Gadolinium-Mischkristall-Pyrochlorphase
US8021742B2 (en) * 2006-12-15 2011-09-20 Siemens Energy, Inc. Impact resistant thermal barrier coating system
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
KR20120015334A (ko) * 2009-05-29 2012-02-21 펄 테라퓨틱스 인코포레이티드 활성제의 호흡기 전달용 조성물, 및 연관된 방법 및 시스템
PT105139B (pt) * 2010-06-01 2013-01-29 Hovione Farmaciencia S A Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos
EP2968152B2 (en) 2013-03-15 2022-06-22 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
MX2015016058A (es) 2013-05-22 2016-12-20 Pearl Therapeutics Inc Composiciones, metodos y sistemas para el suministro por via respiratoria de tres o mas agentes activos.
CN105481933B (zh) * 2015-12-25 2017-09-19 山东京卫制药有限公司 一种合成糠酸莫米松的方法
CN105566437B (zh) * 2015-12-30 2018-07-20 山东京卫制药有限公司 一种8dm衍生物及利用其合成糠酸莫米松的方法
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
PE20240808A1 (es) 2021-07-09 2024-04-18 Astrazeneca Pharmaceuticals Lp Composiciones, metodos y sistemas para la administracion de farmacos en aerosol
WO2023119093A1 (en) 2021-12-20 2023-06-29 Astrazeneca Ab Compositions, methods and systems for aerosol drug delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0057401B1 (en) * 1981-02-02 1984-08-01 Schering Corporation Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
JP4269110B2 (ja) * 1996-06-28 2009-05-27 シェーリング コーポレイション 9α,21―ジハロ―プレグナン―11β,17α―ジオール―20―オンの17―エステルの調製のためのプロセス
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones

Also Published As

Publication number Publication date
JP2001048897A (ja) 2001-02-20
DE69904585T2 (de) 2003-05-15
NZ500555A (en) 2000-11-24
HUP9903747A3 (en) 2001-07-30
DE69904585D1 (de) 2003-01-30
HU227494B1 (en) 2011-07-28
DK1074558T3 (da) 2003-04-07
CA2295455A1 (en) 2001-02-02
IL133752A0 (en) 2001-04-30
AU5602499A (en) 2001-02-08
KR100640066B1 (ko) 2006-10-31
IL133752A (en) 2004-02-19
NO321154B1 (no) 2006-03-27
SI1074558T1 (en) 2003-04-30
ATE229970T1 (de) 2003-01-15
CN1149222C (zh) 2004-05-12
RU2208616C2 (ru) 2003-07-20
PL336452A1 (en) 2001-02-12
PT102343A (pt) 2001-02-28
KR20010020094A (ko) 2001-03-15
ZA996758B (en) 2000-08-30
JP3746174B2 (ja) 2006-02-15
PT102343B (pt) 2003-11-28
EP1074558B1 (en) 2002-12-18
NO995225D0 (no) 1999-10-26
EP1074558A1 (en) 2001-02-07
US6177560B1 (en) 2001-01-23
HUP9903747A2 (hu) 2001-05-28
UA60333C2 (uk) 2003-10-15
CN1282744A (zh) 2001-02-07
CA2295455C (en) 2008-03-25
AU765592B2 (en) 2003-09-25
HRP990341B1 (en) 2003-10-31
PL191103B1 (pl) 2006-03-31
HRP990341A2 (en) 2001-04-30
ES2189354T3 (es) 2003-07-01
HU9903747D0 (en) 1999-12-28

Similar Documents

Publication Publication Date Title
NO995225L (no) Fremgangsmåte ved fremstilling av mometason furoat
ES2134847T3 (es) Derivados de taxol.
AU6675400A (en) Software code protection by obscuring its data-driven form
DE69622556D1 (de) Organisches lösungsmittel enthaltende überzugszusammensetzung, umfassend polyacetoacetat, vernetzer und organosilan
NO983487D0 (no) Derivater av camptothecin for anvendelse ved behandling av kreft
ATE429920T1 (de) Pharmazeutische zusammensetzung und verfahren zur behandlung von hypogonadismus
FI954979A7 (fi) Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
DE69808620D1 (de) Universell verwendbares bluttplasma
AU2002225369A1 (en) Photobase generators, curable compositions prepared by using the same and process of curing
NZ295238A (en) Immunogenic compositions characterised by the carrier being a hydrophobic solvent in the absence of a hydrophilic phase
FI962976A7 (fi) Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta- salpaajaa
DE60006825D1 (de) Serotonerge benzofurane
HUP9700991A2 (hu) Taxoidszármazékok és eljárás előállításukra
NO20000355D0 (no) Fremgangsmåte for fremstilling av cyklopropylacetylen
DE59610629D1 (de) Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine
DK0703907T3 (da) Fremgangsmåde til fremstilling af terapeutisk aktive taxoider
DE69903252D1 (de) Verfahren zur Herstellung der Taxolanalogen 10-Deacetyltaxol A, B und C
DK0937057T3 (da) Hidtil ukendte (-)-enantiomerer af cis-3,4-chromanderivater anvendelige i forebyggelse eller behandling af østrogenrelaterede sygdomme eller syndromer
NO20000805D0 (no) Fremgangsmåte for fremstilling av organiske azider
DK1214315T3 (da) 1,4-Dihydropyridin-5-carboxylsyreesterderivater og fremgangsmåde til fremstilling af samme

Legal Events

Date Code Title Description
MK1K Patent expired